VanEck Pharmaceutical ETF
125 hedge funds and large institutions have $713M invested in VanEck Pharmaceutical ETF in 2025 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 42 increasing their positions, 47 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
2% less funds holding
Funds holding: 127 → 125 (-2)
11% less repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 47
93% less call options, than puts
Call options by funds: $3.59M | Put options by funds: $53.7M
Holders
125
Holding in Top 10
2
Calls
$3.59M
Puts
$53.7M
Top Buyers
| 1 | +$58.9M | |
| 2 | +$46.8M | |
| 3 | +$10.6M | |
| 4 |
Wells Fargo
San Francisco,
California
|
+$8.81M |
| 5 |
JGC
J. Goldman & Co
New York
|
+$6.06M |
Top Sellers
| 1 | -$78.2M | |
| 2 | -$26.3M | |
| 3 | -$11.7M | |
| 4 |
VV
Verity & Verity
Beaufort,
South Carolina
|
-$11.6M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$10.8M |
